Wenyan Xu

1.0k total citations
36 papers, 813 citations indexed

About

Wenyan Xu is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Wenyan Xu has authored 36 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 7 papers in Organic Chemistry and 4 papers in Pharmacology. Recurrent topics in Wenyan Xu's work include Biochemical and Structural Characterization (11 papers), DNA Repair Mechanisms (10 papers) and Mitochondrial Function and Pathology (7 papers). Wenyan Xu is often cited by papers focused on Biochemical and Structural Characterization (11 papers), DNA Repair Mechanisms (10 papers) and Mitochondrial Function and Pathology (7 papers). Wenyan Xu collaborates with scholars based in China, United States and Australia. Wenyan Xu's co-authors include Linlin Zhao, Panpan Liu, Xue‐Qin Song, Zhen Su, Yongbiao Xue, Tai Wang, Guang‐Zhi Zeng, Ning‐Hua Tan, Wenjun He and Jun Tang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Wenyan Xu

36 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenyan Xu China 16 484 196 134 120 101 36 813
Igor Popa Czechia 21 486 1.0× 242 1.2× 479 3.6× 470 3.9× 105 1.0× 59 1.2k
V. Veena India 16 187 0.4× 37 0.2× 316 2.4× 222 1.9× 67 0.7× 34 714
T. Barna United Kingdom 15 380 0.8× 156 0.8× 124 0.9× 70 0.6× 20 0.2× 24 740
Michael Dreyer Germany 19 315 0.7× 184 0.9× 488 3.6× 71 0.6× 16 0.2× 31 979
Н. И. Комарова Russia 15 328 0.7× 96 0.5× 245 1.8× 87 0.7× 19 0.2× 60 736
Mohammed Al-Nuri Palestinian Territory 13 159 0.3× 222 1.1× 151 1.1× 78 0.7× 41 0.4× 29 684
Klaudia Büldt‐Karentzopoulos Germany 8 210 0.4× 51 0.3× 66 0.5× 220 1.8× 96 1.0× 9 525
Jacek Malinowski Poland 8 127 0.3× 80 0.4× 73 0.5× 49 0.4× 22 0.2× 16 347
Kostas Dimas Greece 16 429 0.9× 175 0.9× 158 1.2× 58 0.5× 11 0.1× 18 748
Thomas K. Schoch United States 14 457 0.9× 144 0.7× 117 0.9× 58 0.5× 20 0.2× 20 767

Countries citing papers authored by Wenyan Xu

Since Specialization
Citations

This map shows the geographic impact of Wenyan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyan Xu more than expected).

Fields of papers citing papers by Wenyan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyan Xu. The network helps show where Wenyan Xu may publish in the future.

Co-authorship network of co-authors of Wenyan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyan Xu. A scholar is included among the top collaborators of Wenyan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyan Xu. Wenyan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pang, Xiaojing, Wenyan Xu, Jing Liang, et al.. (2025). Research progress and perspectives of dual-target inhibitors. European Journal of Medicinal Chemistry. 289. 117453–117453. 2 indexed citations
2.
Xu, Wenyan, Mu Chen, Xin Deng, et al.. (2025). Modular Synthesis of Bioactive Selenoheterocycles for Efficient Cancer Therapy via Electrochemical Selenylation/Cyclization. Journal of Medicinal Chemistry. 68(6). 6339–6360. 12 indexed citations
3.
Fang, Xinyue, Yong Zeng, Zile Zhu, et al.. (2024). Electrochemical synthesis of peptide aldehydes via C‒N bond cleavage of cyclic amines. Nature Communications. 15(1). 5181–5181. 25 indexed citations
4.
Tang, Jin, Guodong Zhang, Wenyan Xu, et al.. (2024). DNA sequence and lesion-dependent mitochondrial transcription factor A (TFAM)-DNA-binding modulates DNA repair activities and products. Nucleic Acids Research. 52(22). 14093–14111. 6 indexed citations
5.
Liang, Jing, Yuanyuan Guo, Yang Liu, et al.. (2023). A potent GPX4 degrader to induce ferroptosis in HT1080 cells. European Journal of Medicinal Chemistry. 265. 116110–116110. 15 indexed citations
6.
Liu, Chaoxing, et al.. (2023). Dual chemical labeling enables nucleotide-resolution mapping of DNA abasic sites and common alkylation damage in human mitochondrial DNA. Nucleic Acids Research. 51(13). e73–e73. 11 indexed citations
7.
Xu, Wenyan, et al.. (2022). The 5′-phosphate enhances the DNA-binding and exonuclease activities of human mitochondrial genome maintenance exonuclease 1 (MGME1). Journal of Biological Chemistry. 298(9). 102306–102306. 3 indexed citations
8.
Xu, Wenyan, Jin Tang, & Linlin Zhao. (2022). DNA–protein cross-links between abasic DNA damage and mitochondrial transcription factor A (TFAM). Nucleic Acids Research. 51(1). 41–53. 18 indexed citations
9.
Xu, Wenyan, Yujie Li, Tian‐Jun Gong, & Yao Fu. (2022). Synthesis of gem-Difluorinated 1,3-Dienes via Synergistic Cu/Pd-Catalyzed Borodifluorovinylation of Alkynes. Organic Letters. 24(32). 5884–5889. 8 indexed citations
10.
Xu, Wenyan, et al.. (2020). The dual-catalyzed boryldifluoroallylation of alkynes: an efficient method for the synthesis of skipped gem-difluorodienes. Chemical Communications. 56(15). 2340–2343. 27 indexed citations
11.
Xu, Wenyan, et al.. (2019). Mitochondrial transcription factor A promotes DNA strand cleavage at abasic sites. Proceedings of the National Academy of Sciences. 116(36). 17792–17799. 41 indexed citations
12.
Xu, Wenyan, et al.. (2019). Divalent Cations Alter the Rate-Limiting Step of PrimPol-Catalyzed DNA Elongation. Journal of Molecular Biology. 431(4). 673–686. 13 indexed citations
13.
Xu, Wenyan, et al.. (2015). Kinetic and Structural Mechanisms of (5′S)-8,5′-Cyclo-2′-deoxyguanosine-Induced DNA Replication Stalling. Biochemistry. 54(3). 639–651. 10 indexed citations
14.
Song, Xue‐Qin, et al.. (2014). Structure-based description of a step-by-step synthesis of heterodinuclear ZnIILnIII complexes and their luminescence properties. Inorganica Chimica Acta. 425. 145–153. 41 indexed citations
15.
Xu, Wenyan, et al.. (2012). [Progress in the study of some important natural bioactive cyclopeptides].. PubMed. 47(3). 271–9. 4 indexed citations
16.
Kuang, Bin, et al.. (2011). Antitumor Cyclic Hexapeptides from Rubia Plants: History, Chemistry, and Mechanism (2005–2011). CHIMIA International Journal for Chemistry. 65(12). 952–952. 26 indexed citations
17.
Ji, Chang‐Jiu, Wenjun He, Yu Shen, et al.. (2011). Cyclopeptide Alkaloids from Ziziphus apetala. Journal of Natural Products. 74(12). 2571–2575. 24 indexed citations
18.
Xu, Wenyan, et al.. (2010). Genome-scale analysis and comparison of gene expression profiles in developing and germinated pollen in Oryza sativa. BMC Genomics. 11(1). 338–338. 134 indexed citations
19.
Xu, Wenyan, et al.. (2008). Application of a TLC chemical method to detection of cyclotides in plants. Science Bulletin. 53(11). 1671–1674. 15 indexed citations
20.
Sun, Meihao, Wenyan Xu, Yafang Zhu, Wei-Ai Su, & Zhangcheng Tang. (2001). A simple method forIn Situ hybridization to RNA in guard cells ofVicia Faba L.: The expression of aquaporins in guard cells. Plant Molecular Biology Reporter. 19(2). 129–135. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026